Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Sales | 22,206,060 | 21,874,380 | 21,451,840 | 29,167,560 | 30,192,120 |
| Cost of Goods | 6,718,240 | 6,935,880 | 6,774,730 | 12,037,970 | 12,783,120 |
| Gross Profit | 15,487,810 | 14,938,500 | 14,677,100 | 17,129,590 | 17,409,000 |
| Operating Expenses | 10,465,430 | 10,164,580 | 10,011,120 | 12,476,860 | 12,609,360 |
| Operating Income | 5,022,631 | 4,774,801 | 4,666,721 | 4,653,701 | 4,799,760 |
| Other Income | 804,359 | 688,619 | 82,539 | -2,563,121 | -115,920 |
| Pre-tax Income | 5,826,990 | 5,463,420 | 4,749,260 | 2,090,580 | 4,683,840 |
| Income Tax | 1,253,770 | 1,298,580 | 1,151,710 | 234,250 | 1,132,320 |
| Net Income Continuous | 4,554,760 | 4,146,900 | 3,585,170 | 1,854,720 | 3,541,440 |
| Net Income | $4,554,750 | $4,146,900 | $3,585,160 | $1,854,720 | $3,541,440 |
| EPS Basic Total Ops | 1.64 | 1.67 | 1.42 | 1.32 | 2.54 |
| EPS Basic Continuous Ops | 1.64 | 1.67 | 1.42 | 1.32 | 2.54 |
| EBITDA(a) | $5,022,631 | $4,774,801 | $4,666,721 | $4,653,701 | $4,799,760 |